Microbot Medical (FRA:CY9D) FCF Margin % : 0.00% (As of Dec. 2024)

View and export this data going back to . Start your Free Trial

What is Microbot Medical FCF Margin %?

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Microbot Medical's Free Cash Flow for the three months ended in Dec. 2024 was €-1.62 Mil. Microbot Medical's Revenue for the three months ended in Dec. 2024 was €0.00 Mil. Therefore, Microbot Medical's FCF Margin % for the quarter that ended in Dec. 2024 was 0.00%.

As of today, Microbot Medical's current FCF Yield % is -10.48%.

The historical rank and industry rank for Microbot Medical's FCF Margin % or its related term are showing as below:

FRA:CY9D's FCF Margin % is not ranked ^*
in the Medical Devices & Instruments industry.
Industry Median: -3.29
* Ranked among companies with meaningful FCF Margin % only.

Microbot Medical FCF Margin % Historical Data

The historical data trend for Microbot Medical's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Microbot Medical FCF Margin % Chart

Microbot Medical Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

FCF Margin %

Get a 7-Day Free Trial

Microbot Medical Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
FCF Margin %	Get a 7-Day Free Trial															-	-	-	-	-

Competitive Comparison of Microbot Medical's FCF Margin %

For the Medical Instruments & Supplies subindustry, Microbot Medical's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Microbot Medical's FCF Margin % Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Microbot Medical's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Microbot Medical's FCF Margin % falls into.

Save Embed

;

Save Embed

;

Microbot Medical FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Microbot Medical's FCF Margin for the fiscal year that ended in Dec. 2024 is calculated as

FCF Margin	=	Free Cash Flow (A: Dec. 2024 )	/	Revenue (A: Dec. 2024 )
	=	-8.454	/	0
	=	%

Microbot Medical's FCF Margin for the quarter that ended in Dec. 2024 is calculated as

FCF Margin	=	Free Cash Flow (Q: Dec. 2024 )	/	Revenue (Q: Dec. 2024 )
	=	-1.622	/	0
	=	%

Microbot Medical FCF Margin % Related Terms

Thank you for viewing the detailed overview of Microbot Medical's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Microbot Medical Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Microbot Medical Inc (FRA:CY9D) » Definitions » FCF Margin %

Comparable Companies

Traded in Other Exchanges

MBOT:USA CY9D:Germany

Address

175 Derby Street, Bld 27, Hingham, MA, USA, 02043

Website

https://www.microbotmedical.com

Microbot Medical Inc is a clinical-stage medical device company specializing in the research, design and development of next-generation robotic endoluminal surgery devices targeting the minimally invasive surgery space. It is focused on leveraging its robotic technologies to redefine surgical robotics while improving surgical outcomes for patients. Using its LIBERTY technological platform, the company is developing the first-ever fully disposable robot for various endovascular interventional procedures.

Microbot Medical Headlines

No Headlines